According to a new report published by Introspective Market Research, titled, “Peripheral Intravenous Catheter Market by Type, Application, and End-User,” the Global Peripheral Intravenous Catheter Market Size was valued at USD 1.86 Billion in 2024 and is projected to reach USD 2.98 Billion by 2032, growing at a CAGR of 5.40% from 2025 to 2032.The Peripheral Intravenous (PIV) Catheter Market is witnessing steady growth due to the increasing prevalence of chronic diseases, rising hospital admissions, and the need for efficient vascular access solutions. Peripheral intravenous catheters are medical devices used to deliver fluids, medications, or nutrients directly into a patient’s bloodstream. They offer a minimally invasive alternative to traditional vascular access methods, providing safety, ease of use, and cost-effectiveness in clinical procedures.
PIV catheters are extensively used in hospitals, clinics, and home care settings, making them an essential component of intravenous therapy. Advances in catheter materials, such as biocompatible polymers and antimicrobial coatings, are enhancing device performance and patient safety. The growing focus on reducing hospital-acquired infections and improving patient comfort has further accelerated the adoption of advanced PIV catheters.
The market is also supported by the rising trend of shorter hospital stays, outpatient treatments, and home healthcare services, which require reliable and easy-to-use intravenous devices. As healthcare infrastructure expands in emerging economies, demand for PIV catheters is expected to continue growing steadily over the forecast period.
The Peripheral Intravenous Catheter Market is segmented into Type, Application, and End-User.
-
By Type: Standard Catheter, Safety Catheter, and Integrated Catheter Systems
-
By Application: Medication Administration, Blood Collection, Fluid Therapy
-
By End-User: Hospitals, Clinics, Ambulatory Care Centers, and Home Healthcare
A key growth driver of the Peripheral Intravenous Catheter Market is the increasing prevalence of chronic illnesses and rising demand for intravenous therapy across healthcare settings. PIV catheters provide a safe, cost-effective, and minimally invasive method to deliver fluids, medications, and nutrition directly into the bloodstream. The growing patient population requiring long-term therapies, such as chemotherapy, antibiotics, and parenteral nutrition, is significantly driving market growth.
The expanding adoption of safety-engineered PIV catheters presents a major market opportunity. Safety catheters help prevent needle-stick injuries, reduce infection risks, and comply with stringent regulatory standards. As hospitals and clinics focus on improving patient safety and operational efficiency, the demand for innovative catheter designs and advanced materials is expected to rise. Additionally, the growth of home healthcare services offers new avenues for market expansion, particularly in developed economies.
Peripheral Intravenous Catheter Market, Segmentation
The Peripheral Intravenous Catheter Market is segmented on the basis of Type, Application, and End-User.
By Type
The Safety Catheter segment accounted for the largest market share in 2024, driven by its ability to reduce accidental needle-stick injuries and prevent infections. Healthcare providers are increasingly adopting safety catheters to comply with occupational safety regulations and improve patient care outcomes.
By Application
The Medication Administration segment dominated in 2024, as PIV catheters are widely used to administer antibiotics, chemotherapy drugs, and other medications directly into the bloodstream. Their precision, reliability, and ease of use make them indispensable in clinical treatments.
Some of The Leading/Active Market Players Are:
- Becton, Dickinson and Company (U.S.)
- B. Braun Melsungen AG (Germany)
- Smiths Medical (U.K.)
- Terumo Corporation (Japan)
- Medtronic plc (Ireland)
- Fresenius Kabi AG (Germany)
- Nipro Corporation (Japan)
- Teleflex Incorporated (U.S.)
- C.R. Bard, Inc. (U.S.)
- Halyard Health, Inc. (U.S.)
- Other active players.
Key Industry Developments
- In March 2024, Becton, Dickinson and Company launched a next-generation safety PIV catheter with improved anti-microbial coating, aimed at reducing bloodstream infections in hospital settings.
- In September 2023, Terumo Corporation introduced a new integrated catheter system that simplifies intravenous therapy for home healthcare, enhancing safety and ease of use for patients and caregivers.
Key Findings of the Study
- Safety Catheters dominated the market in 2024.
- Medication Administration is the leading application segment.
- Hospitals remain the primary end-users of PIV catheters.
- Growth is driven by rising chronic disease prevalence and IV therapy demand.
- Adoption of advanced materials and safety features is a key market trend.
